These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
504 related articles for article (PubMed ID: 23876384)
1. Design, characterization, and in vitro cellular inhibition and uptake of optimized genistein-loaded NLC for the prevention of posterior capsular opacification using response surface methodology. Zhang W; Li X; Ye T; Chen F; Sun X; Kong J; Yang X; Pan W; Li S Int J Pharm; 2013 Sep; 454(1):354-66. PubMed ID: 23876384 [TBL] [Abstract][Full Text] [Related]
2. Optimization and physicochemical characterization of a triamcinolone acetonide-loaded NLC for ocular antiangiogenic applications. Araújo J; Gonzalez-Mira E; Egea MA; Garcia ML; Souto EB Int J Pharm; 2010 Jun; 393(1-2):167-75. PubMed ID: 20362042 [TBL] [Abstract][Full Text] [Related]
3. Enhanced cellular uptake and anti-proliferating effect of chitosan hydrochlorides modified genistein loaded NLC on human lens epithelial cells. Zhang W; Liu J; Zhang Q; Li X; Yu S; Yang X; Kong J; Pan W Int J Pharm; 2014 Aug; 471(1-2):118-26. PubMed ID: 24858387 [TBL] [Abstract][Full Text] [Related]
4. Sustained-release genistein from nanostructured lipid carrier suppresses human lens epithelial cell growth. Liu JL; Zhang WJ; Li XD; Yang N; Pan WS; Kong J; Zhang JS Int J Ophthalmol; 2016; 9(5):643-9. PubMed ID: 27275415 [TBL] [Abstract][Full Text] [Related]
5. Optimizing flurbiprofen-loaded NLC by central composite factorial design for ocular delivery. Gonzalez-Mira E; Egea MA; Souto EB; Calpena AC; García ML Nanotechnology; 2011 Jan; 22(4):045101. PubMed ID: 21169662 [TBL] [Abstract][Full Text] [Related]
6. Preparation and characterization of nanostructured lipid carriers loaded traditional Chinese medicine, zedoary turmeric oil. Zhao XL; Yang CR; Yang KL; Li KX; Hu HY; Chen DW Drug Dev Ind Pharm; 2010 Jul; 36(7):773-80. PubMed ID: 20136496 [TBL] [Abstract][Full Text] [Related]
7. Tacrolimus-loaded nanostructured lipid carriers for oral delivery - Optimization of production and characterization. Khan S; Shaharyar M; Fazil M; Baboota S; Ali J Eur J Pharm Biopharm; 2016 Nov; 108():277-288. PubMed ID: 27449630 [TBL] [Abstract][Full Text] [Related]
9. Development of nanostructured lipid carriers containing salicyclic acid for dermal use based on the Quality by Design method. Kovács A; Berkó S; Csányi E; Csóka I Eur J Pharm Sci; 2017 Mar; 99():246-257. PubMed ID: 28012940 [TBL] [Abstract][Full Text] [Related]
10. Emodin loaded solid lipid nanoparticles: preparation, characterization and antitumor activity studies. Wang S; Chen T; Chen R; Hu Y; Chen M; Wang Y Int J Pharm; 2012 Jul; 430(1-2):238-46. PubMed ID: 22465546 [TBL] [Abstract][Full Text] [Related]
11. Berberine loaded nanostructured lipid carrier for Alzheimer's disease: Design, statistical optimization and enhanced in vivo performance. Raju M; Kunde SS; Auti ST; Kulkarni YA; Wairkar S Life Sci; 2021 Nov; 285():119990. PubMed ID: 34592234 [TBL] [Abstract][Full Text] [Related]
12. Impact of lipid dynamic behavior on physical stability, in vitro release and skin permeation of genistein-loaded lipid nanoparticles. Andrade LM; de Fátima Reis C; Maione-Silva L; Anjos JL; Alonso A; Serpa RC; Marreto RN; Lima EM; Taveira SF Eur J Pharm Biopharm; 2014 Sep; 88(1):40-7. PubMed ID: 24816130 [TBL] [Abstract][Full Text] [Related]
13. A novel oral delivery system consisting in "drug-in cyclodextrin-in nanostructured lipid carriers" for poorly water-soluble drug: vinpocetine. Lin C; Chen F; Ye T; Zhang L; Zhang W; Liu D; Xiong W; Yang X; Pan W Int J Pharm; 2014 Apr; 465(1-2):90-6. PubMed ID: 24530388 [TBL] [Abstract][Full Text] [Related]
14. PEGylated nanostructured lipid carriers (PEG-NLC) as a novel drug delivery system for biochanin A. Wang L; Luo Q; Lin T; Li R; Zhu T; Zhou K; Ji Z; Song J; Jia B; Zhang C; Chen W; Zhu G Drug Dev Ind Pharm; 2015; 41(7):1204-12. PubMed ID: 25010850 [TBL] [Abstract][Full Text] [Related]
15. Preparation and characteristics of nanostructured lipid carriers for control-releasing progesterone by melt-emulsification. Yuan H; Wang LL; Du YZ; You J; Hu FQ; Zeng S Colloids Surf B Biointerfaces; 2007 Nov; 60(2):174-9. PubMed ID: 17656075 [TBL] [Abstract][Full Text] [Related]
16. Preparation of Coenzyme Q10 nanostructured lipid carriers for epidermal targeting with high-pressure microfluidics technique. Chen S; Liu W; Wan J; Cheng X; Gu C; Zhou H; Chen S; Zhao X; Tang Y; Yang X Drug Dev Ind Pharm; 2013 Jan; 39(1):20-8. PubMed ID: 23116283 [TBL] [Abstract][Full Text] [Related]
17. Preparation and characterization of fenofibrate-loaded nanostructured lipid carriers for oral bioavailability enhancement. Tran TH; Ramasamy T; Truong DH; Choi HG; Yong CS; Kim JO AAPS PharmSciTech; 2014 Dec; 15(6):1509-15. PubMed ID: 25035071 [TBL] [Abstract][Full Text] [Related]
18. Long chain lipid based tamoxifen NLC. Part I: preformulation studies, formulation development and physicochemical characterization. Shete H; Patravale V Int J Pharm; 2013 Sep; 454(1):573-83. PubMed ID: 23535345 [TBL] [Abstract][Full Text] [Related]
19. Lipid nanoparticles for skin penetration enhancement-correlation to drug localization within the particle matrix as determined by fluorescence and parelectric spectroscopy. Lombardi Borgia S; Regehly M; Sivaramakrishnan R; Mehnert W; Korting HC; Danker K; Röder B; Kramer KD; Schäfer-Korting M J Control Release; 2005 Dec; 110(1):151-63. PubMed ID: 16297487 [TBL] [Abstract][Full Text] [Related]
20. Photo-responsive and NGR-mediated multifunctional nanostructured lipid carrier for tumor-specific therapy. Yang Y; Xie X; Yang Y; Zhang H; Mei X J Pharm Sci; 2015 Apr; 104(4):1328-39. PubMed ID: 25630979 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]